BACKGROUND: Asthma is now widely recognised to be a heterogeneous disease. The last two decades have seen the identification of a number of biological targets and development of various novel therapies. Despite this, asthma still represents a significant health and economic burden worldwide. Why some individuals should continue to suffer remains unclear.METHODS: The Wessex Asthma Cohort of Difficult Asthma (WATCH) is an ongoing 'real-life', prospective study of patients in the University Hospital Southampton Foundation Trust (UHSFT) Difficult Asthma service. Research data capture is aligned with the extensive clinical characterisation required of a commissioned National Health Service (NHS) Specialist Centre for Severe Asthma. Data acquisit...
International audiencePURPOSE OF REVIEW: Asthma is a heterogeneous disease constituted by overlappin...
Introduction: The U-BIOPRED cohort presents an exceptional opportunity to longitudinally monitor dis...
PURPOSE: The West Sweden Asthma Study (WSAS) is a population-representative longitudinal study estab...
The WATCH Study is a longitudinal study of patients under the Difficult Asthma Clinic at University ...
Background: The Wessex AsThma CoHort of difficult asthma (WATCH) is a large prospective observationa...
WATCH is a longitudinal observational study of patients under the Difficult Asthma Clinic at Univers...
Asthma is a chronic inflammatory disease characterised by airflow obstruction and reversibility. The...
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma...
Background: Patients with difficult-to-control asthma consume 50-60% of healthcare costs attributed ...
Background: Patients with difficult-to-control asthma consume 50-60% of healthcare costs attributed ...
Background: Patients with difficult-to-control asthma consume 50–60% of healthcare costs attributed ...
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma...
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma...
ABSTRACT: Five per cent of asthmatics remain symptomatic despite high-dose treatment. The aim of the...
International audiencePURPOSE OF REVIEW: Asthma is a heterogeneous disease constituted by overlappin...
International audiencePURPOSE OF REVIEW: Asthma is a heterogeneous disease constituted by overlappin...
Introduction: The U-BIOPRED cohort presents an exceptional opportunity to longitudinally monitor dis...
PURPOSE: The West Sweden Asthma Study (WSAS) is a population-representative longitudinal study estab...
The WATCH Study is a longitudinal study of patients under the Difficult Asthma Clinic at University ...
Background: The Wessex AsThma CoHort of difficult asthma (WATCH) is a large prospective observationa...
WATCH is a longitudinal observational study of patients under the Difficult Asthma Clinic at Univers...
Asthma is a chronic inflammatory disease characterised by airflow obstruction and reversibility. The...
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma...
Background: Patients with difficult-to-control asthma consume 50-60% of healthcare costs attributed ...
Background: Patients with difficult-to-control asthma consume 50-60% of healthcare costs attributed ...
Background: Patients with difficult-to-control asthma consume 50–60% of healthcare costs attributed ...
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma...
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma...
ABSTRACT: Five per cent of asthmatics remain symptomatic despite high-dose treatment. The aim of the...
International audiencePURPOSE OF REVIEW: Asthma is a heterogeneous disease constituted by overlappin...
International audiencePURPOSE OF REVIEW: Asthma is a heterogeneous disease constituted by overlappin...
Introduction: The U-BIOPRED cohort presents an exceptional opportunity to longitudinally monitor dis...
PURPOSE: The West Sweden Asthma Study (WSAS) is a population-representative longitudinal study estab...